daclizumab

Ligand id: 6880

Name: daclizumab

Immunopharmacology Disease
Disease X-Refs Comment References
Relapsing-remitting multiple sclerosis Disease Ontology: DOID:2378
Approval covers use of the daclizumab beta form of the drug to treat RRMS.